Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours
广谱酪氨酸激酶抑制剂JNJ-26483327对晚期实体瘤患者的I期及药理学研究
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/sj.bjc.6605867
I R H M Konings, M J A de Jonge, H Burger, A van der Gaast, L E C van Beijsterveldt, H Winkler, J Verweij, Z Yuan, P Hellemans, F A L M Eskens
